Corporate ActionMay 12, 2026, 05:27 PM
Amesite Registers 4.84M Shares for Resale; Warrants Could Yield $5.38M
AI Summary
Amesite Inc. filed an S-1 registration statement for the resale of up to 4,836,245 shares of common stock by selling stockholders. This includes shares issued directly and those issuable upon the exercise of various warrants, which could generate approximately $5.38 million in gross proceeds for the company if exercised for cash. The company, which has pivoted to AI-powered healthcare solutions, reported significant net losses in recent fiscal years and expressed substantial doubt about its ability to continue as a going concern.
Key Highlights
- Amesite registered up to 4,836,245 shares of Common Stock for resale by selling stockholders.
- The offering includes 418,118 shares of Common Stock and shares issuable from various warrants.
- Warrants include Pre-Funded (696,866), Series A-1 (1,811,850), Series A-2 (1,811,850), and Placement Agent (97,561).
- Cash exercise of all warrants could result in gross proceeds of approximately $5.38 million to Amesite.
- Common stock outstanding prior to offering was 5,434,867 shares; 10,271,112 shares after full warrant exercise.
- Amesite reported net losses of $3.62 million in fiscal 2025 and $4.40 million in fiscal 2024.
- The company stated substantial doubt about its ability to continue as a going concern.
- Amesite's common stock last traded at $1.05 per share on Nasdaq Capital Market (AMST).
Price Impact
More from AMST